Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riad Agbaria

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Drug Design, Development and Therapy|October 7, 2014
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product developmentOmri Wolk, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2015
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplayAvital Beig, Riad Agbaria, Arik Dahan
Plos One|July 23, 2013
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsAvital Beig, Riad Agbaria, Arik Dahan
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2003
Phosphorylation of 3'-azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and at termRiad Agbaria, Esther Manor, Jacob Barak, et al.
International Journal of Pharmaceutics|May 11, 2015
The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tractMoran Zur, Noa Cohen, Riad Agbaria, et al.
Expert Opinion on Drug Delivery|June 19, 2012
Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approachArik Dahan, Mustafa Khamis, Riad Agbaria, et al.
Drug Design, Development and Therapy|July 1, 2015
Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seedRiad Agbaria, Adi Gabarin, Arik Dahan, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 9, 2006
Entrapment of retroviral vector producer cells in three-dimensional alginate scaffolds for potential use in cancer gene therapyMona Dvir-Ginzberg, Alexander Konson, Smadar Cohen, et al.
Antiviral Research|May 30, 2006
The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agentVictor E Marquez, Stephen H Hughes, Shizuko Sei, et al.
Tissue Engineering|September 19, 2003
Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and functionMona Dvir-Ginzberg, Iris Gamlieli-Bonshtein, Riad Agbaria, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|October 7, 2014
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product developmentOmri Wolk, Riad Agbaria, Arik Dahan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2015
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplayAvital Beig, Riad Agbaria, Arik Dahan
Plos One|July 23, 2013
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsAvital Beig, Riad Agbaria, Arik Dahan
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2003
Phosphorylation of 3'-azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and at termRiad Agbaria, Esther Manor, Jacob Barak, et al.
International Journal of Pharmaceutics|May 11, 2015
The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tractMoran Zur, Noa Cohen, Riad Agbaria, et al.
Expert Opinion on Drug Delivery|June 19, 2012
Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approachArik Dahan, Mustafa Khamis, Riad Agbaria, et al.
Drug Design, Development and Therapy|July 1, 2015
Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seedRiad Agbaria, Adi Gabarin, Arik Dahan, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 9, 2006
Entrapment of retroviral vector producer cells in three-dimensional alginate scaffolds for potential use in cancer gene therapyMona Dvir-Ginzberg, Alexander Konson, Smadar Cohen, et al.
Antiviral Research|May 30, 2006
The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agentVictor E Marquez, Stephen H Hughes, Shizuko Sei, et al.
Tissue Engineering|September 19, 2003
Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and functionMona Dvir-Ginzberg, Iris Gamlieli-Bonshtein, Riad Agbaria, et al.
Pageof 4